Innovative Medicines Canada, an association that represents drugmakers in Canada, has challenged the overhaul of Canada’s drug-pricing regime.
Swiss pharmaceutical company Novartis has united with BenevolentAI to aid in the discovery and development of new treatments.
State sovereignty principles don’t give the Board of Regents of the University of Texas the right to bring a lawsuit in an improper venue, according to the US Court of Appeals for the Federal Circuit.
Americans now hold less regard for big pharma than any other industry, according to a poll from US analytics company Gallup.
Indian drugmaker Lupin and German pharma company Boehringer Ingelheim have formed an alliance to develop a therapy for patients with difficult-to-treat cancers.
CAR-T cells have achieved hugely-positive outcomes in treating forms of cancer that are otherwise difficult to treat.
US-based Vertex Pharmaceuticals has announced it will pay $950 million to acquire Semma Therapeutics, a biotechnology company focused on researching a cure for Type 1 diabetes.
Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.
An alliance of companies that use gene-editing technologies has released a bioethical framework, as controversy over gene-editing continues.
Nicole Jadeja, the former co-head of life sciences at Fieldfisher, has joined Pinsent Masons as a partner in its London office.